NCT00679523 - Safety and Efficacy Study of Subjects With Onychomycosis of the Great Toenail | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions

Onychomycosis

Interventions

DRUG

AN2690 Solution, 5.0%

Once daily application for 180 days

DRUG

AN2690 Solution, 7.5%

Once daily application for 180 days

Trial Locations (9)

Unidad de Investigación en Salud (UIS), Chihuahua City

"Hospital Dr. Angel Leaño", Guadalajara

Instituto Dermatologico Jalisciense, Guadalajara

Centro Dermatologico Pascua, Mexico City

CIF-BIOTEC Medica Sur., Mexico City

IMIC, Mexico City

Hospital Universitario Dr. José Eleuterio González, Monterrey

MIRC / OCA Hospital, Monterrey

ISSEMYM, Toluca